Characteristic | Progression-free survival | Overall survival | Score | ||
---|---|---|---|---|---|
HR (95%CI) | P | HR (95%CI) | P | ||
IPI risk group | |||||
Low (0–1) | Reference | Reference | 0 | ||
Low-intermediate (2) | 2.003 (1.411–2.845) | < 0.001 | 2.401 (1.593–3.618) | < 0.001 | 2 |
High-intermediate (3) | 2.922 (2.053–4.159) | < 0.001 | 3.346 (2.211–5.064) | < 0.001 | 3 |
High (4–5) | 4.073 (2.684–6.182) | < 0.001 | 5.341 (3.301–8.644) | < 0.001 | 5 |
β2-microglobulin level | |||||
Normal | Reference | Reference | 0 | ||
Elevated | 1.543 (1.181–2.016) | 0.001 | 1.411 (1.040–1.913) | 0.027 | 1 |
PLT (×109/L) | |||||
≥ 157 | Reference | Reference | 0 | ||
< 157 | 1.433 (1.010–2.034) | 0.044 | 1.548 (1.038–2.308) | 0.032 | 1 |
RDW (%) | |||||
< 14.5 | Reference | Reference | 0 | ||
≥ 14.5 | 1.438 (1.022–2.023) | 0.037 | 1.758 (1.214–2.547) | 0.003 | 1 |